Last updated: 17 July 2019 at 7:44am EST

Bros. Advisors Lpbaker Feli... Net Worth




The estimated Net Worth of Bros. Advisors Lpbaker Feli... is at least $338 million dollars as of 30 March 2016. Bros Feli owns over 1,449,090 units of Acadia Pharmaceuticals Inc stock worth over $337,619,998 and over the last 11 years Bros sold ACAD stock worth over $0.

Bros Feli ACAD stock SEC Form 4 insiders trading

Bros has made over 2 trades of the Acadia Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Bros bought 1,449,090 units of ACAD stock worth $39,241,357 on 30 March 2016.

The largest trade Bros's ever made was buying 1,449,090 units of Acadia Pharmaceuticals Inc stock on 30 March 2016 worth over $39,241,357. On average, Bros trades about 329,234 units every 126 days since 2014. As of 30 March 2016 Bros still owns at least 21,167,398 units of Acadia Pharmaceuticals Inc stock.

You can see the complete history of Bros Feli stock trades at the bottom of the page.



Insiders trading at Acadia Pharmaceuticals Inc

Over the last 20 years, insiders at Acadia Pharmaceuticals Inc have traded over $21,409,958 worth of Acadia Pharmaceuticals Inc stock and bought 29,279,665 units worth $647,484,672 . The most active insiders traders include Bros. Advisors Lp14159, L.P..., Bros. Advisors Lp667, L.P.B... et Carl L Gordon. On average, Acadia Pharmaceuticals Inc executives and independent directors trade stock every 17 days with the average trade being worth of $2,248,934. The most recent stock trade was executed by Mark C. Schneyer on 16 August 2024, trading 9,733 units of ACAD stock currently worth $148,720.



What does Acadia Pharmaceuticals Inc do?

acadia pharmaceuticals (nasdaq: acad) is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in related central nervous system (cns) disorders. all of acadia's product candidates emanate from internal discoveries. we believe that they offer innovative therapeutic approaches that may provide significant advantages relative to current therapies. acadia’s history is rooted in science and strong leadership in cns research. our proprietary drug discovery platform has led to a portfolio of drug candidates with large unmet needs. since the beginning, we have been dedicated to discovering, developing and commercializing innovative therapies that improve the lives of patients suffering from such disorders. acadia is headquartered in san diego. the city represents the second largest biotechnology industry cluster in the united states, home to over 400 companies, as well as the salk institute for biological studies



What does Acadia Pharmaceuticals Inc's logo look like?

Acadia Pharmaceuticals Inc logo

Complete history of Bros Feli stock trades at Acadia Pharmaceuticals Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
30 Mar 2016 Bros. Advisors Lpbaker Feli...
Acheter 1,449,090 $27.08 $39,241,357
30 Mar 2016
21,167,398
5 Mar 2014 Bros. Advisors Lpbaker Feli...
Acheter 526,316 $28.50 $15,000,006
5 Mar 2014
452,540


Acadia Pharmaceuticals Inc executives and stock owners

Acadia Pharmaceuticals Inc executives and other stock owners filed with the SEC include: